Review of clinical trials and controversy of first drug of choice in Parkinson's disease

被引：0
|
作者：
Rana, A. Q.
机构：
来源：
MOVEMENT DISORDERS | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S274 / S275
页数：2
相关论文
共 50 条
  • [1] The choice of first symptomatic drug treatment in Parkinson's disease
    Keranen, T.
    Virta, L. J.
    MOVEMENT DISORDERS, 2015, 30 : S96 - S96
  • [2] Suicide behaviors in antiParkinsonian drug clinical trials for Parkinson's disease
    Teodoro, T.
    Nzwalo, H.
    Guedes, L.
    Coelho, M.
    Rosa, M. M.
    Ferreira, J. J.
    MOVEMENT DISORDERS, 2014, 29 : S309 - S310
  • [3] A review of disease progression models of Parkinson's disease and applications in clinical trials
    Venuto, Charles S.
    Potter, Nicholas B.
    Dorsey, E. Ray
    Kieburtz, Karl
    MOVEMENT DISORDERS, 2016, 31 (07) : 947 - 956
  • [4] Drug-induced Parkinson's disease A clinical review
    Bohlega, Saeed A.
    Al-Foghom, Nurah B.
    NEUROSCIENCES, 2013, 18 (03) : 215 - 221
  • [5] Nutritional and dietary clinical trials for Parkinson's disease: a narrative review
    Giannakis, Alexandros
    Chondrogiorgi, Maria
    Konitsiotis, Spiridon
    Sidiropoulos, Christos
    JOURNAL OF NEURAL TRANSMISSION, 2025, 132 (04) : 519 - 536
  • [6] Drug Repurposing for Parkinson's Disease: The International Linked Clinical Trials experience
    Stott, Simon R. W.
    Wyse, Richard K.
    Brundin, Patrik
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [7] Clinical trials of neuroprotection for Parkinson's disease
    LeWitt, PA
    NEUROLOGY, 2004, 63 (07) : S23 - S31
  • [8] Neuroprotection in Parkinson's disease: Clinical trials
    Stocchi, F
    Olanow, CW
    ANNALS OF NEUROLOGY, 2003, 53 : S87 - S97
  • [9] Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment
    D. van de Vijver
    R. Roos
    P. Jansen
    A. Porsius
    A. de Boer
    European Journal of Clinical Pharmacology, 2002, 58 : 157 - 161
  • [10] Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment
    van de Vijver, DAMC
    Roos, RAC
    Jansen, PAF
    Porsius, AJ
    de Boer, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (02) : 157 - 161
12345